🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase I double-blind, randomized, placebo-controlled study in 50 ...
Status
Completed
Location
Saint Louis University - Center for Vaccine Development
Start Date
2018-08-15
Trial ID
NCT03553940
Evaluate safety and tolerability of TIVa or TIVb vaccine in healthy childre...
Status
Completed
Location
320, Novartis Investigational Site
Start Date
2013-05
Trial ID
NCT01857206
Treatments Being Tested
The study primarily aims to evaluate immunogenicity and safety of influenza...
Status
Completed
Location
5
Start Date
2007-10
Trial ID
NCT00579345
The purpose of this research study is to compare how the body reacts to dif...
Status
Completed
Location
Stanford University
Start Date
2006-10
Trial ID
NCT00382980
Treatments Being Tested
The present study is designed to confirm the safety and immunogenicity of c...
Status
Completed
Location
Rostock University, Department of Tropical Medicine and Infectious Diseases
Start Date
2013-08
Trial ID
NCT01880697
Treatments Being Tested
A randomized, double-blinded, controlled, Phase I clinical trial to assess ...
Status
Completed
Location
Korea University Guro Hospital
Start Date
2012-09
Trial ID
NCT03893669
The present study is the first study designed to evaluate safety, tolerabil...
Status
Completed
Location
Site 09
Start Date
2007-10
Trial ID
NCT00645411
This is to evaluate immunogenicity based on EMEA/CHMP criteria, and safety ...
Status
Completed
Location
CPC Clinic, Medipolis Medical Research Institute
Start Date
2010-03
Trial ID
NCT01069367
Treatments Being Tested
This is a prospective, randomized randomized immunologic study of response ...
Status
Completed
Location
Valleywise Health Comprehensive Health Center
Start Date
2023-09-25
Trial ID
NCT06020118
A total of 18,000 eligible subjects (or 6,000 subject distributed evenly be...
Status
Active Not Recruiting
Location
Naval Medical Center San Diego
Start Date
2018-11-06
Trial ID
NCT03734237